DOCSLIB.ORG

Coronavirus HKU1 Infection in the United States Frank Esper,* Carla Weibel,† David Ferguson,† Marie L

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Coronavirus HKU1 Infection in the United States Frank Esper,* Carla Weibel,† David Ferguson,† Marie L Coronavirus HKU1 Infection in the United States Frank Esper,* Carla Weibel,† David Ferguson,† Marie L. Landry,† and Jeffrey S. Kahn† In 2005, a new human coronavirus, HCoV-HKU1, was The identification of the severe acute respiratory syn- identified in Hong Kong. We screened respiratory speci- drome–associated CoV in 2003 sparked renewed interest mens collected from December 16, 2001, to December 15, in the study of HCoV (7), and 4 previously unidentified 2002, from children <5 years of age who tested negative for HCoV have subsequently been discovered. HCoV-NL63, respiratory syncytial virus, parainfluenza viruses, influenza HCoV-NL, and the New Haven coronavirus (HCoV-NH) virus, and adenovirus for HCoV-HKU1 by reverse transcrip- tion–polymerase chain reaction. Overall, 1,048 respiratory are closely related group I CoV and likely represent strains specimens from 851 children were tested, and 9 HCoV- of the same species of virus (8–10). HCoV-NL63 and HKU1–positive children (1%) were identified, 2 of whom HCoV-NL were originally identified by cell culture tech- had 2 positive specimens. Children who had HCoV-HKU1 niques, while HCoV-NH was discovered by using broadly infection had evidence of either upper or lower respiratory reactive CoV molecular probes. These related viruses were tract infection or both. Two patients had disease beyond the identified in both children and adults with respiratory tract respiratory tract. HCoV-HKU1 was identified from disease. HCoV-NH was found in 8.8% of children <5 years December 2001 to February 2002. Sequence analyses of age whose specimens originally tested negative for suggest that a single strain was circulating. HCoV-HKU1 is RSV, influenza virus, parainfluenza viruses, and aden- therefore likely circulating in the United States and is asso- ciated with upper and lower respiratory tract disease. oviruses (10). Furthermore, these newly discovered virus- es may be the cause of disease beyond the respiratory tract. In a case-control study, HCoV-NH was found to be associ- ower respiratory tract disease accounts for ≈4 million ated with Kawasaki disease (11), although these data are Ldeaths annually worldwide (1). Viruses such as influen- controversial (12,13). za virus, respiratory syncytial virus (RSV), and parain- In 2005, Woo et al. reported a novel group II CoV, des- fluenza viruses are responsible for much of this respiratory ignated HCoV-HKU1, from a 71-year-old man with pneu- tract infection. However, in a substantial proportion of res- monia (14) who had recently returned to Hong Kong from piratory tract disease, no pathogen is identified (2). the Shenzhen, China. As in the discovery of HCoV-NH Coronaviruses (CoV) infect a wide variety of mammals (10), this virus was detected with molecular probes. and birds, causing disease of the respiratory tract, gastroin- Although growth of HCoV-HKU1 in multiple cell lines testinal tract, and central nervous system. These viruses was unsuccessful, the complete genomic sequence was may be transmitted from species to species (3). In humans, obtained. Phylogenetic analysis showed that this new CoV have been associated with community-acquired upper group II CoV is most closely related to the mouse hepati- respiratory tract infections (4). Human CoV (HCoV) have tis virus and is distinct from HCoV-OC43, the only other also been implicated in outbreaks of diarrhea as well as in known group II HCoV. Screening of 400 nasopharyngeal demyelinating disorders of the central nervous system, aspirates by reverse transcription–polymerase chain reac- though these data are controversial (5,6). The study and tion (RT-PCR) with HCoV-HKU1–specific primers identification of HCoV have been hampered by the diffi- showed 1 other HCoV-HKU1 isolate from a 35-year-old culty in propagating these viruses in vitro. woman with pneumonia. After the original report, HCoV- HKU1 was identified in 10 patients in northern Australia (15). Respiratory samples were collected between May *Case Western Reserve University School of Medicine, Cleveland, and August (winter in Australia) and screened by RT-PCR Ohio, USA; and †Yale University School of Medicine, New Haven, Connecticut, USA with both nonspecific CoV and specific HKU1 primers. Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 12, No. 5, May 2006 775 RESEARCH Most HCoV-HKU1–positive samples originated from chil- and 72°C for 1 min; and completed with a final extension dren in the later winter months. However, the seasonal and cycle of 72°C for 10 min. Each set of reverse transcription geographic distribution of this virus is still unclear. To and polymerase chain reactions contained appropriate neg- address these issues, we sought to determine whether ative controls. Sequencing was performed on an Applied HCoV-HKU1 circulated in New Haven, Connecticut, and Biosystems 3730 XL DNA Analyzer (Foster City, CA, to define clinical characteristics associated with HCoV- USA) at the W.M. Keck Biotechnology Resource Lab, HKU1 infection in infants and children. Yale University School of Medicine. Methods Clinical Data Medical records of all HCoV-HKU1–positive children Clinical Specimens were reviewed. Demographic data, history of illness, and Nasopharyngeal swabs and aspirates submitted to the results of clinical examination and laboratory studies were clinical virology laboratory at Yale–New Haven Hospital recorded on a standard collection form. The Yale from December 16, 2001, to December 15, 2002, for res- University Human Investigation Committee approved col- piratory virus diagnosis were initially tested for RSV, lection of specimens and clinical data. parainfluenza viruses (types 1–3), influenza A and B virus- es, and adenovirus by direct immunofluorescence assay. Results Respiratory specimens were screened for human metap- From December 16, 2001, to December 15, 2002, 1,048 neumovirus (16) and HCoV-NH (10) by RT-PCR. respiratory specimens from 851 children were tested by Specimens originated from the emergency department, RT-PCR for HCoV-HKU1. Specimens from 9 of these inpatient wards, intensive care units, and the hospital-affil- children (1%) tested positive for HCoV-HKU1. Specimens iated primary care outpatient clinic and were submitted at from these children tested negative for RSV, parainfluenza the discretion of the medical teams. Clinical specimens viruses (types 1–3), influenza A and B viruses, and aden- from children <5 years of age that tested negative by direct ovirus by direct immunofluorescence assay as well as immunofluorescence assay were tested for HCoV-HKU1 human metapneumovirus and HCoV-NH by RT-PCR. Two as described below. Collection of specimens and clinical children had 2 specimens that tested positive for HCoV- data was approved by the Yale University Human HKU1. For each of these 2 children, the positive speci- Investigation Committee and compliant with Health mens were collected <10 days apart. Children whose Insurance Portability and Accountability Act regulations. specimens tested positive for HCoV-HKU1 infection had clinical evidence of either upper or lower respiratory tract RT-PCR Screening infection or both (Table). The most common clinical find- RNA from each respiratory specimen was extracted ings were rhinorrhea (100%), cough (67%), fever (67%), with the QIAamp Viral RNA Mini Kit (Qiagen, Valencia, and abnormal breath sounds on auscultation (44%). CA, USA), according to the manufacturer’s protocol. Hypoxia (oxygen saturation of <90%) was observed in Random hexamer primers synthesized by the oligonu- only 1 patient. Chest radiographs were obtained for 4 cleotide laboratory, Department of Pathology, Yale patients, all of whom had abnormal findings that included University School of Medicine, were used to create a peribronchial cuffing, atelectasis, hyperinflation, or infil- cDNA library for each specimen. Reverse transcription trates. One patient (patient 3) had respiratory decompensa- reactions were performed with MuMLV RT (New England tion requiring ventilatory support and was admitted to the Biolabs, Beverly, MA, USA), according to the manufactur- pediatric intensive care unit. This patient had no history of er’s specifications. Each cDNA was subsequently screened underlying illness, had not been premature, and was 1 for the presence of HCoV-HKU1 by polymerase chain month of age at the time of specimen collection. reaction with HotStar Taq polymerase (Qiagen), according Two patients had evidence of disease beyond the respi- to the manufacturer’s specification. Primers used to screen ratory tract. One patient (patient 1) was hospitalized for respiratory specimens were identical to those described by new-onset seizures. Workup for a central nervous system Woo et al. (14). The forward primer, 5′ GGTTGGGAT- infection, including a lumbar puncture and head magnetic TATCCTAAATGTGA, and reverse primer, 5′ CCATCAT- resonance imaging, was unrevealing. Although a febrile CACTCAAAATCATCATA, produce an amplicon that seizure remains a possible diagnosis, no evidence of fever corresponds to nucleotides 15409–15848 of the HCoV- was reported by the mother or noted during the hospital HKU1 replicase 1B gene (GenBank accession no. stay. A second patient (patient 7) was hospitalized with AY597011) and yields an amplicon of 439 bp. hepatitis. This patient had undergone liver transplantation Amplification cycles were as follows: 95°C for 15 min; 3 months before admission. Immunosuppressive medica- followed by 40 cycles of 94°C for 1 min, 55°C for 1 min, tions included tacrolimus and prednisolone. The patient 776
Load more

Recommended publications
  • Rational Design of Human Metapneumovirus Live Attenuated Vaccine Candidates by Inhibiting Viral Messenger RNA Cap Methyltransferase
    Rational design of human metapneumovirus live attenuated vaccine candidates by inhibiting viral messenger RNA cap methyltransferase DISSERTATION Presented in Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy in the Graduate School of The Ohio State University By Yu Zhang The Graduate Program in Food Science and Technology The Ohio State University 2014 Dissertation Committee: Dr. Jianrong Li, advisor Dr. Melvin Pascall Dr. Stefan Niewiesk Dr. Tracey Papenfuss Copyrighted by Yu Zhang 2014 Abstract Human metapneumovirus (hMPV) is a newly discovered paramyxovirus, first identified in 2001 in the Netherlands in infants and children with acute respiratory tract infections. Soon after its discovery, hMPV was recognized as a globally prevalent pathogen. Epidemiological studies suggest that 5 to 15% of all respiratory tract infections in infants and young children are caused by hMPV, a proportion second only to that of human respiratory syncytial virus (hRSV). Despite major efforts, there are no therapeutics or vaccines available for hMPV. In the last decade, approaches to generate vaccines employing viral proteins or inactivated vaccines have failed either due to a lack of immunogenicity or the potential for causing enhanced pulmonary disease upon natural infection with the same virus. In contrast to inactivated vaccines, enhanced lung diseases have not been observed for candidate live attenuated hMPV vaccines. Thus, a living attenuated vaccine is the most promising vaccine candidate for hMPV. However, it has been a challenge to identify an hMPV vaccine strain that has an optimal balance between attenuation and immunogenicity. In addition, hMPV grows poorly in cell culture and the growth is trypsin-dependent.
    [Show full text]
  • On the Coronaviruses and Their Associations with the Aquatic Environment and Wastewater
    water Review On the Coronaviruses and Their Associations with the Aquatic Environment and Wastewater Adrian Wartecki 1 and Piotr Rzymski 2,* 1 Faculty of Medicine, Poznan University of Medical Sciences, 60-812 Pozna´n,Poland; [email protected] 2 Department of Environmental Medicine, Poznan University of Medical Sciences, 60-806 Pozna´n,Poland * Correspondence: [email protected] Received: 24 April 2020; Accepted: 2 June 2020; Published: 4 June 2020 Abstract: The outbreak of Coronavirus Disease 2019 (COVID-19), a severe respiratory disease caused by betacoronavirus SARS-CoV-2, in 2019 that further developed into a pandemic has received an unprecedented response from the scientific community and sparked a general research interest into the biology and ecology of Coronaviridae, a family of positive-sense single-stranded RNA viruses. Aquatic environments, lakes, rivers and ponds, are important habitats for bats and birds, which are hosts for various coronavirus species and strains and which shed viral particles in their feces. It is therefore of high interest to fully explore the role that aquatic environments may play in coronavirus spread, including cross-species transmissions. Besides the respiratory tract, coronaviruses pathogenic to humans can also infect the digestive system and be subsequently defecated. Considering this, it is pivotal to understand whether wastewater can play a role in their dissemination, particularly in areas with poor sanitation. This review provides an overview of the taxonomy, molecular biology, natural reservoirs and pathogenicity of coronaviruses; outlines their potential to survive in aquatic environments and wastewater; and demonstrates their association with aquatic biota, mainly waterfowl. It also calls for further, interdisciplinary research in the field of aquatic virology to explore the potential hotspots of coronaviruses in the aquatic environment and the routes through which they may enter it.
    [Show full text]
  • Metapneumovirus
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Erasmus University Digital Repository Metapneumovirus determinants of host range and replication Miranda de Graaf ISBN: 978-90-9023746-6 The research described in this thesis was conducted at the Department of Virology of Erasmus MC, Rotterdam, The Netherlands, with financial support from the framework five grant “Hammocs” from the European Union and MedImmune Vaccines, USA. Printing of this thesis was financially supported by: Vironovative B.V., Viroclinics B.V., Greiner Bio-One. Cover art by Rosanne van der Meer and Miranda de Graaf Cartoons by Dirk-Jan de Graaf (p 61 and 143) Layout design by Aukje van Meeteren Printed by PrintPartners Ipskamp B.V Metapneumovirus determinants of host range and replication Metapneumovirus determinanten van gastheerspecificiteit en replicatie Proefschrift ter verkrijging van de graad van doctor aan de Erasmus Universiteit Rotterdam op gezag van de rector magnificus Prof.dr. S.W.J. Lamberts en volgens besluit van het College voor Promoties. De openbare verdediging zal plaatsvinden op donderdag 15 januari 2009 om 13.30 uur door: Miranda de Graaf geboren te Bergen (N.H.) Promotiecommissie Promotoren: Prof.dr. R.A.M. Fouchier Prof.dr. A.D.M.E. Osterhaus Overige leden: Prof.dr. A. van Belkum Prof.dr. M.P.G. Koopmans Prof.dr. B.K. Rima CONTENTS Page Chapter 1. General Introduction 1 Chapter 2. Recovery of human metapneumovirus genetic lineages A and B from 17 cloned cDNA Journal of Virology, 2004 Chapter 3. An improved plaque reduction virus neutralization assay for human 33 metapneumovirus Journal of Virological Methods, 2007 Chapter 4.
    [Show full text]
  • The COVID-19 Pandemic: a Comprehensive Review of Taxonomy, Genetics, Epidemiology, Diagnosis, Treatment, and Control
    Journal of Clinical Medicine Review The COVID-19 Pandemic: A Comprehensive Review of Taxonomy, Genetics, Epidemiology, Diagnosis, Treatment, and Control Yosra A. Helmy 1,2,* , Mohamed Fawzy 3,*, Ahmed Elaswad 4, Ahmed Sobieh 5, Scott P. Kenney 1 and Awad A. Shehata 6,7 1 Department of Veterinary Preventive Medicine, Ohio Agricultural Research and Development Center, The Ohio State University, Wooster, OH 44691, USA; [email protected] 2 Department of Animal Hygiene, Zoonoses and Animal Ethology, Faculty of Veterinary Medicine, Suez Canal University, Ismailia 41522, Egypt 3 Department of Virology, Faculty of Veterinary Medicine, Suez Canal University, Ismailia 41522, Egypt 4 Department of Animal Wealth Development, Faculty of Veterinary Medicine, Suez Canal University, Ismailia 41522, Egypt; [email protected] 5 Department of Radiology, University of Massachusetts Medical School, Worcester, MA 01655, USA; [email protected] 6 Avian and Rabbit Diseases Department, Faculty of Veterinary Medicine, Sadat City University, Sadat 32897, Egypt; [email protected] 7 Research and Development Section, PerNaturam GmbH, 56290 Gödenroth, Germany * Correspondence: [email protected] (Y.A.H.); [email protected] (M.F.) Received: 18 March 2020; Accepted: 21 April 2020; Published: 24 April 2020 Abstract: A pneumonia outbreak with unknown etiology was reported in Wuhan, Hubei province, China, in December 2019, associated with the Huanan Seafood Wholesale Market. The causative agent of the outbreak was identified by the WHO as the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), producing the disease named coronavirus disease-2019 (COVID-19). The virus is closely related (96.3%) to bat coronavirus RaTG13, based on phylogenetic analysis.
    [Show full text]
  • Identification of New Respiratory Viruses in the New Millennium
    Viruses 2015, 7, 996-1019; doi:10.3390/v7030996 OPEN ACCESS viruses ISSN 1999-4915 www.mdpi.com/journal/viruses Review Identification of New Respiratory Viruses in the New Millennium Michael Berry 1,2, Junaid Gamieldien 1 and Burtram C. Fielding 2,* 1 South African National Bioinformatics Institute, University of the Western Cape, Western Cape 7535, South Africa; E-Mails: [email protected] (M.B.); [email protected] (J.G.) 2 Molecular Biology and Virology Laboratory, Department of Medical BioSciences, Faculty of Natural Sciences, University of the Western Cape, Western Cape 7535, South Africa * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +27-21-959-3620; Fax: +27-21-959-3125. Academic Editor: Eric O. Freed Received: 11 December 2014 / Accepted: 26 February 2015 / Published: 6 March 2015 Abstract: The rapid advancement of molecular tools in the past 15 years has allowed for the retrospective discovery of several new respiratory viruses as well as the characterization of novel emergent strains. The inability to characterize the etiological origins of respiratory conditions, particularly in children, led several researchers to pursue the discovery of the underlying etiology of disease. In 2001, this led to the discovery of human metapneumovirus (hMPV) and soon following that the outbreak of Severe Acute Respiratory Syndrome coronavirus (SARS-CoV) promoted an increased interest in coronavirology and the latter discovery of human coronavirus (HCoV) NL63 and HCoV-HKU1. Human bocavirus, with its four separate lineages, discovered in 2005, has been linked to acute respiratory tract infections and gastrointestinal complications. Middle East Respiratory Syndrome coronavirus (MERS-CoV) represents the most recent outbreak of a completely novel respiratory virus, which occurred in Saudi Arabia in 2012 and presents a significant threat to human health.
    [Show full text]
  • Drawing Comparisons Between SARS-Cov-2 and the Animal Coronaviruses
    microorganisms Review Drawing Comparisons between SARS-CoV-2 and the Animal Coronaviruses Souvik Ghosh 1,* and Yashpal S. Malik 2 1 Department of Biomedical Sciences, Ross University School of Veterinary Medicine, Basseterre 334, Saint Kitts and Nevis 2 College of Animal Biotechnology, Guru Angad Dev Veterinary and Animal Science University, Ludhiana 141004, India; [email protected] * Correspondence: [email protected] or [email protected]; Tel.: +1-869-4654161 (ext. 401-1202) Received: 23 September 2020; Accepted: 19 November 2020; Published: 23 November 2020 Abstract: The COVID-19 pandemic, caused by a novel zoonotic coronavirus (CoV), SARS-CoV-2, has infected 46,182 million people, resulting in 1,197,026 deaths (as of 1 November 2020), with devastating and far-reaching impacts on economies and societies worldwide. The complex origin, extended human-to-human transmission, pathogenesis, host immune responses, and various clinical presentations of SARS-CoV-2 have presented serious challenges in understanding and combating the pandemic situation. Human CoVs gained attention only after the SARS-CoV outbreak of 2002–2003. On the other hand, animal CoVs have been studied extensively for many decades, providing a plethora of important information on their genetic diversity, transmission, tissue tropism and pathology, host immunity, and therapeutic and prophylactic strategies, some of which have striking resemblance to those seen with SARS-CoV-2. Moreover, the evolution of human CoVs, including SARS-CoV-2, is intermingled with those of animal CoVs. In this comprehensive review, attempts have been made to compare the current knowledge on evolution, transmission, pathogenesis, immunopathology, therapeutics, and prophylaxis of SARS-CoV-2 with those of various animal CoVs.
    [Show full text]
  • Occurrence and Significance of Human Coronaviruses and Human Bocaviruses in Acute Gastroenteritis of Childhood AUT 2153 MINNA PALONIEMI
    MINNA PALONIEMI Occurrence and Significance of Human Coronaviruses and Human Bocaviruses in Acute ... Occurrence and Significance of Human Coronaviruses Bocaviruses in PALONIEMI MINNA Acta Universitatis Tamperensis 2153 MINNA PALONIEMI Occurrence and Significance of Human Coronaviruses and Human Bocaviruses in Acute Gastroenteritis of Childhood AUT 2153 AUT MINNA PALONIEMI Occurrence and Significance of Human Coronaviruses and Human Bocaviruses in Acute Gastroenteritis of Childhood ACADEMIC DISSERTATION To be presented, with the permission of the Board of the School of Medicine of the University of Tampere, for public discussion in the Jarmo Visakorpi auditorium of the Arvo building, Lääkärinkatu 1, Tampere, on 15 April 2016, at 12 o’clock. UNIVERSITY OF TAMPERE MINNA PALONIEMI Occurrence and Significance of Human Coronaviruses and Human Bocaviruses in Acute Gastroenteritis of Childhood Acta Universitatis Tamperensis 2153 Tampere University Press Tampere 2016 ACADEMIC DISSERTATION University of Tampere, School of Medicine Vaccine Research Center Finland Supervised by Reviewed by Professor emeritus Timo Vesikari Docent Tapani Hovi University of Tampere University of Helsinki Finland Finland Professor emeritus Olli Ruuskanen University of Turku Finland The originality of this thesis has been checked using the Turnitin OriginalityCheck service in accordance with the quality management system of the University of Tampere. Copyright ©2016 Tampere University Press and the author Cover design by Mikko Reinikka Distributor: [email protected] https://verkkokauppa.juvenes.fi Acta Universitatis Tamperensis 2153 Acta Electronica Universitatis Tamperensis 1652 ISBN 978-952-03-0078-4 (print) ISBN 978-952-03-0079-1 (pdf) ISSN-L 1455-1616 ISSN 1456-954X ISSN 1455-1616 http://tampub.uta.fi Suomen Yliopistopaino Oy – Juvenes Print Tampere 2016 441 729 Painotuote To my family, Abstract Acute gastroenteritis (AGE) remains an important cause of child hospitalization in Finland, although rotavirus vaccination has reduced the number of AGE hospitalizations significantly.
    [Show full text]
  • Betacoronavirus Genomes: How Genomic Information Has Been Used to Deal with Past Outbreaks and the COVID-19 Pandemic
    International Journal of Molecular Sciences Review Betacoronavirus Genomes: How Genomic Information Has Been Used to Deal with Past Outbreaks and the COVID-19 Pandemic Alejandro Llanes 1 , Carlos M. Restrepo 1 , Zuleima Caballero 1 , Sreekumari Rajeev 2 , Melissa A. Kennedy 3 and Ricardo Lleonart 1,* 1 Centro de Biología Celular y Molecular de Enfermedades, Instituto de Investigaciones Científicas y Servicios de Alta Tecnología (INDICASAT AIP), Panama City 0801, Panama; [email protected] (A.L.); [email protected] (C.M.R.); [email protected] (Z.C.) 2 College of Veterinary Medicine, University of Florida, Gainesville, FL 32610, USA; [email protected] 3 College of Veterinary Medicine, University of Tennessee, Knoxville, TN 37996, USA; [email protected] * Correspondence: [email protected]; Tel.: +507-517-0740 Received: 29 May 2020; Accepted: 23 June 2020; Published: 26 June 2020 Abstract: In the 21st century, three highly pathogenic betacoronaviruses have emerged, with an alarming rate of human morbidity and case fatality. Genomic information has been widely used to understand the pathogenesis, animal origin and mode of transmission of coronaviruses in the aftermath of the 2002–2003 severe acute respiratory syndrome (SARS) and 2012 Middle East respiratory syndrome (MERS) outbreaks. Furthermore, genome sequencing and bioinformatic analysis have had an unprecedented relevance in the battle against the 2019–2020 coronavirus disease 2019 (COVID-19) pandemic, the newest and most devastating outbreak caused by a coronavirus in the history of mankind. Here, we review how genomic information has been used to tackle outbreaks caused by emerging, highly pathogenic, betacoronavirus strains, emphasizing on SARS-CoV, MERS-CoV and SARS-CoV-2.
    [Show full text]
  • Human Metapneumovirus
    F1000Research 2018, 7(F1000 Faculty Rev):135 Last updated: 17 JUL 2019 REVIEW Human metapneumovirus - what we know now [version 1; peer review: 2 approved] Nazly Shafagati, John Williams Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA First published: 01 Feb 2018, 7(F1000 Faculty Rev):135 ( Open Peer Review v1 https://doi.org/10.12688/f1000research.12625.1) Latest published: 01 Feb 2018, 7(F1000 Faculty Rev):135 ( https://doi.org/10.12688/f1000research.12625.1) Reviewer Status Abstract Invited Reviewers Human metapneumovirus (HMPV) is a leading cause of acute respiratory 1 2 infection, particularly in children, immunocompromised patients, and the elderly. HMPV, which is closely related to avian metapneumovirus subtype version 1 C, has circulated for at least 65 years, and nearly every child will be infected published with HMPV by the age of 5. However, immunity is incomplete, and 01 Feb 2018 re-infections occur throughout adult life. Symptoms are similar to those of other respiratory viral infections, ranging from mild (cough, rhinorrhea, and fever) to more severe (bronchiolitis and pneumonia). The preferred method F1000 Faculty Reviews are written by members of for diagnosis is reverse transcription-polymerase chain reaction as HMPV the prestigious F1000 Faculty. They are is difficult to culture. Although there have been many advances made in the commissioned and are peer reviewed before past 16 years since its discovery, there are still no US Food and Drug publication to ensure that the final, published version Administration-approved antivirals or vaccines available to treat HMPV. Both small animal and non-human primate models have been established is comprehensive and accessible.
    [Show full text]
  • RSV and HMPV Infections in 3D Tissue Cultures: Mechanisms Involved in Virus-Host and Virus-Virus Interactions
    viruses Article RSV and HMPV Infections in 3D Tissue Cultures: Mechanisms Involved in Virus-Host and Virus-Virus Interactions Johan Geiser 1 , Guy Boivin 2, Song Huang 3, Samuel Constant 3, Laurent Kaiser 1,4, Caroline Tapparel 1 and Manel Essaidi-Laziosi 1,4,* 1 Department of Microbiology and Molecular Medicine, Faculty of Medicine, University of Geneva, 1211 Geneva, Switzerland; [email protected] (J.G.); [email protected] (L.K.); [email protected] (C.T.) 2 Research Center in Infectious Diseases, CHU of Quebec and Laval University, Quebec City, QC 47762, Canada; [email protected] 3 Epithelix Sàrl, 1228 Geneva, Switzerland; [email protected] (S.H.); [email protected] (S.C.) 4 Division of Infectious Diseases, Geneva University Hospital, 1211 Geneva, Switzerland * Correspondence: [email protected] Abstract: Respiratory viral infections constitute a global public health concern. Among prevalent respiratory viruses, two pneumoviruses can be life-threatening in high-risk populations. In young children, they constitute the first cause of hospitalization due to severe lower respiratory tract diseases. A better understanding of their pathogenesis is still needed as there are no approved efficient anti-viral nor vaccine against pneumoviruses. We studied Respiratory Syncytial virus (RSV) and human Metapneumovirus (HMPV) in single and dual infections in three-dimensional cultures, a highly relevant model to study viral respiratory infections of the airway epithelium. Our investigation showed that HMPV is less pathogenic than RSV in this model. Compared to RSV, Citation: Geiser, J.; Boivin, G.; HMPV replicated less efficiently, induced a lower immune response, did not block cilia beating, and Huang, S.; Constant, S.; Kaiser, L.; was more sensitive to IFNs.
    [Show full text]
  • Structure Unveils Relationships Between RNA Virus Polymerases
    viruses Article Structure Unveils Relationships between RNA Virus Polymerases Heli A. M. Mönttinen † , Janne J. Ravantti * and Minna M. Poranen * Molecular and Integrative Biosciences Research Programme, Faculty of Biological and Environmental Sciences, University of Helsinki, Viikki Biocenter 1, P.O. Box 56 (Viikinkaari 9), 00014 Helsinki, Finland; heli.monttinen@helsinki.fi * Correspondence: janne.ravantti@helsinki.fi (J.J.R.); minna.poranen@helsinki.fi (M.M.P.); Tel.: +358-2941-59110 (M.M.P.) † Present address: Institute of Biotechnology, Helsinki Institute of Life Sciences (HiLIFE), University of Helsinki, Viikki Biocenter 2, P.O. Box 56 (Viikinkaari 5), 00014 Helsinki, Finland. Abstract: RNA viruses are the fastest evolving known biological entities. Consequently, the sequence similarity between homologous viral proteins disappears quickly, limiting the usability of traditional sequence-based phylogenetic methods in the reconstruction of relationships and evolutionary history among RNA viruses. Protein structures, however, typically evolve more slowly than sequences, and structural similarity can still be evident, when no sequence similarity can be detected. Here, we used an automated structural comparison method, homologous structure finder, for comprehensive comparisons of viral RNA-dependent RNA polymerases (RdRps). We identified a common structural core of 231 residues for all the structurally characterized viral RdRps, covering segmented and non-segmented negative-sense, positive-sense, and double-stranded RNA viruses infecting both prokaryotic and eukaryotic hosts. The grouping and branching of the viral RdRps in the structure- based phylogenetic tree follow their functional differentiation. The RdRps using protein primer, RNA primer, or self-priming mechanisms have evolved independently of each other, and the RdRps cluster into two large branches based on the used transcription mechanism.
    [Show full text]
  • Respiratory Pathogen Panel
    510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY A. 510(k) Number: K152386 B. Purpose for Submission: This is a new 510(k) application for a qualitative Real-Time Reverse Transcription Polymerase Chain Reaction (RT-PCR) assay used with the MAGPIX instrument for the in vitro qualitative detection of Influenza A virus (with subtype differentiation), Influenza B virus, Respiratory Syncytial virus (RSV) A and RSV B, Coronaviruses 229E, OC43, NL63 and HKU1, Human Metapneumovirus, Rhinovirus/Enterovirus, Adenovirus, Parainfluenza virus Types 1, 2, 3, and 4, Human Bocavirus, Chlamydophila pneumoniae, and Mycoplasma pneumoniae in nasopharyngeal swab (NPS) specimens from symptomatic human patients. C. Measurand: Influenza A RNA: Flu A Matrix (M) gene, Flu A H1 (HA) gene, Flu A H3 (HA) gene Influenza B RNA: Flu B Matrix (M) gene RSV A and RSV B: RNA L Polymerase gene Coronaviruses 229E, OC43 and NL63 RNA: Nucleocapsidprotein (N) gene Coronavirus HKU1: open reading frame 1 ab Human Metapneumovirus RNA: Phosphoprotein (P) gene Rhinovirus/Enterovirus RNA: 5’-UTR Adenovirus DNA: Hexon gene Parainfluenza virus RNA: Parainfluenza 1 HN gene, Parainfluenza 2 and 3 NP gene, Parainfluenza virus 4 phosphoprotein (P) gene Human Bocavirus DNA: NP1 gene Chlamydophila pneumoniae DNA: rpoB gene Mycoplasma pneumoiae DNA: P1 gene D. Type of Test: Real-Time Reverse Transcription Polymerase Chain Reaction (RT-PCR) E. Applicant: Luminex Molecular Diagnostics, Inc. F. Proprietary and Established Names: NxTAG® Respiratory Pathogen Panel 1 G. Regulatory Information:
    [Show full text]